AU709413B2 - Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants - Google Patents

Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants Download PDF

Info

Publication number
AU709413B2
AU709413B2 AU43720/96A AU4372096A AU709413B2 AU 709413 B2 AU709413 B2 AU 709413B2 AU 43720/96 A AU43720/96 A AU 43720/96A AU 4372096 A AU4372096 A AU 4372096A AU 709413 B2 AU709413 B2 AU 709413B2
Authority
AU
Australia
Prior art keywords
drug
excipient
composition
guar gum
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43720/96A
Other languages
English (en)
Other versions
AU4372096A (en
Inventor
Syed A Altaf
David R Friend
Eric H. Kuhrts
Jagdish Parasrampuria
Karen Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amarin Development AB
Original Assignee
Cibus Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cibus Pharmaceutical Inc filed Critical Cibus Pharmaceutical Inc
Publication of AU4372096A publication Critical patent/AU4372096A/en
Application granted granted Critical
Publication of AU709413B2 publication Critical patent/AU709413B2/en
Assigned to VENTURE LENDING reassignment VENTURE LENDING Alteration of Name(s) in Register under S187 Assignors: CIBUS PHARMACEUTICAL, INC.
Assigned to AMARIN DEVELOPMENT AB reassignment AMARIN DEVELOPMENT AB Alteration of Name(s) in Register under S187 Assignors: VENTURE LENDING
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
AU43720/96A 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants Ceased AU709413B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34851594A 1994-12-01 1994-12-01
US08/348515 1994-12-01
PCT/US1995/015593 WO1996016638A1 (en) 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Publications (2)

Publication Number Publication Date
AU4372096A AU4372096A (en) 1996-06-19
AU709413B2 true AU709413B2 (en) 1999-08-26

Family

ID=23368363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43720/96A Ceased AU709413B2 (en) 1994-12-01 1995-11-30 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants

Country Status (9)

Country Link
EP (1) EP0793485A4 (zh)
JP (1) JPH10509981A (zh)
CN (1) CN1172429A (zh)
AU (1) AU709413B2 (zh)
CA (1) CA2205351A1 (zh)
FI (1) FI972304A0 (zh)
MX (1) MX9704043A (zh)
NO (1) NO972486L (zh)
WO (1) WO1996016638A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IL119627A (en) 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
EP0974343B1 (en) * 1998-07-22 2004-09-29 Pharma Pass II LLC Process for manufacturing a solid metoprolol composition
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
SE0003125D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Modified polymers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546448A (en) * 1975-03-17 1979-05-23 Hoffmann La Roche Sustained-release formulations
US5147655A (en) * 1987-03-13 1992-09-15 A/S Alfred Benzon Oral composition containing particles comprising an active substance
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327938A (en) * 1969-12-17 1973-08-22 Sucrest Corp Composition for use in forming tablets
DE2130545A1 (de) * 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
AU5745394A (en) * 1992-12-30 1994-08-15 Fmc Corporation Readily available konjac glucomannan sustained release excipient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1546448A (en) * 1975-03-17 1979-05-23 Hoffmann La Roche Sustained-release formulations
US5147655A (en) * 1987-03-13 1992-09-15 A/S Alfred Benzon Oral composition containing particles comprising an active substance
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets

Also Published As

Publication number Publication date
WO1996016638A1 (en) 1996-06-06
MX9704043A (es) 1998-02-28
EP0793485A4 (en) 1998-08-26
CN1172429A (zh) 1998-02-04
NO972486L (no) 1997-07-31
JPH10509981A (ja) 1998-09-29
EP0793485A1 (en) 1997-09-10
FI972304A (fi) 1997-05-30
CA2205351A1 (en) 1996-06-06
AU4372096A (en) 1996-06-19
FI972304A0 (fi) 1997-05-30
NO972486D0 (no) 1997-05-30

Similar Documents

Publication Publication Date Title
US5451409A (en) Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5601842A (en) Sustained release drug formulation containing a tramadol salt
US4695591A (en) Controlled release dosage forms comprising hydroxypropylmethylcellulose
US20110071137A1 (en) Process for preparing sustained release tablets
RU2325163C2 (ru) Композиции с пролонгированным высвобождением, включающие ламотригин
JPH08500110A (ja) ブプロピオン含有持続放出型錠剤
US20080050429A1 (en) Low flush niacin formulation
EP0234670A2 (en) Sustained-release pharmaceutical formulation containing xanthan gum
CZ2001901A3 (cs) Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu
IL104192A (en) Pharmaceutical dosage forms having prolonged release rate of zero order of the active ingredient
US20090069275A1 (en) Low flush niacin formulation
AU5290698A (en) Modified release matrix formulation of cefaclor and cephalexin
JP2000511170A (ja) 医薬組成物
US20020119192A1 (en) Controlled release formulations for oral administration
AU709413B2 (en) Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
WO2004078111A2 (en) Extended release minocycline compositions and processes for their preparation
MXPA97004043A (en) Assortment of pharmacy of sustained release using a rubber of hydrocoloid in powder obtained from top plants
CA2205442C (en) Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
MXPA05004338A (es) Composiciones de liberacion sostenida que contienen alfuzosin.
WO2003011256A1 (en) Oral controlled release pharmaceutical composition of a prokinetic agent
US5993860A (en) NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: VENTURE LENDING

Free format text: FORMER OWNER WAS: CIBUS PHARMACEUTICAL, INC.

PC Assignment registered

Owner name: AMARIN DEVELOPMENT COMPANY

Free format text: FORMER OWNER WAS: VENTURE LENDING

TH Corrigenda

Free format text: IN VOL 15, NO 32, PAGE(S) 6967 UNDER THE HEADING ASSIGNMENTS REGISTERED THE NAME OF THE APPLICANT IN REGARD TO PATENT NUMBER 709413 SHOULD READ: AMARIN DEVELOPMENT AB